Key facts
- Notable investors include China Medical System, Silver Increscence Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Baiyiyuan Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Baiyiyuan Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Baiyiyuan Biotech
Manufacturer of advanced biomedical materials intended for tissue repair and enhancing clinical performance in medical applications. The company offers biocompatible polymers, precision-engineered composites, controlled degradation properties, and customizable structural configurations, enabling healthcare providers, research institutions, and medical device manufacturers with the equipment and supplies needed for various treatments.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2011
- Employees
- 29
- Website
- biomedmat.com/
- Ownership
- Privately Held (backing)
Baiyiyuan Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Baiyiyuan Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Baiyiyuan Biotech in its N-PORT filings yet. We sweep new filings monthly.